According to an article in EurekAlert by Emma Mason, new research shows that more children are surviving cancer in Britain when participating in clinical trials. In fact, the article states that overall only 28% of children diagnosed with cancer between 1966-1970...
According to an article on Outsourcing-Pharma.com, a new study indicates that the regulation of clinical trials in other regions of the world is too rigorous, urging pharma firms and CROs to create designs that are universal. The article entitled, “Trial regulation in...
Pearl Pathways is excited to announce the recent hiring of J. Ellen Looney as an IRB administrator. Ellen is well experienced and has Pearl Pathways CEO, Diana Caldwell, excited to have her as part of the Pearl team, “Our staff and clients are lucky to have Ellen...
Several sources have recently pointed to possible links between poor patient adherence during clinical drug trials and unexpected adverse effects—as well as personal injury cases—once the drug is approved and marketed. Chief among these sources is the Consumer Health...
